2007, 1. Aufl., RGS-IBG book series, ISBN 1405127309, xii, 251
Publics and the Cityinvestigates struggles over the making of urban publics, considering how the production, management and regulation of ‘public spaces’ has...
City and town life | Public spaces | City planning | Urban policy | Human Geography | SOCIAL SCIENCE | Case studies | Australia
City and town life | Public spaces | City planning | Urban policy | Human Geography | SOCIAL SCIENCE | Case studies | Australia
Book
2014, ISBN 095714704X, ix, 346 pages
Book
International Journal of Urban and Regional Research, ISSN 0309-1317, 05/2013, Volume 37, Issue 3, pp. 941 - 956
In many cities around the world we are presently witnessing the growth of, and interest in, a range of micro‐spatial urban practices that are reshaping urban...
Henri Lefebvre | Madrid Street Advertising Takeover | BUGA UP | do‐it‐yourself urbanism | right to the city | New York Street Advertising Takeover | Jacques Rancière | Do-it-yourself urbanism | Right to the city | URBAN STUDIES | GEOGRAPHY | PLANNING & DEVELOPMENT | Community gardens | Analysis | City planning | Democracy | Politics | Cities | Urban areas | Do it yourself--DIY | Australia | U.S.A
Henri Lefebvre | Madrid Street Advertising Takeover | BUGA UP | do‐it‐yourself urbanism | right to the city | New York Street Advertising Takeover | Jacques Rancière | Do-it-yourself urbanism | Right to the city | URBAN STUDIES | GEOGRAPHY | PLANNING & DEVELOPMENT | Community gardens | Analysis | City planning | Democracy | Politics | Cities | Urban areas | Do it yourself--DIY | Australia | U.S.A
Journal Article
Environment and Planning A, ISSN 0308-518X, 3/2017, Volume 49, Issue 3, pp. 537 - 554
Through the actions of activists involved in the Arab Spring uprisings, European anti-austerity movements and the Occupy and Umbrella movements among others,...
counterpublics | Public space | occupation | Aboriginal Tent Embassy | Indigenous Sovereignty | Land Rights | ENVIRONMENTAL STUDIES | GEOGRAPHY
counterpublics | Public space | occupation | Aboriginal Tent Embassy | Indigenous Sovereignty | Land Rights | ENVIRONMENTAL STUDIES | GEOGRAPHY
Journal Article
Progress in Human Geography, ISSN 0309-1325, 10/2015, Volume 39, Issue 5, pp. 543 - 559
This paper uses Jacque Rancière's understanding of politics to ask what makes cities political entities. We review existing urban geography debates to identify...
critical theory | Urban politics | democracy | Rancière | urban geography
critical theory | Urban politics | democracy | Rancière | urban geography
Journal Article
Antipode, ISSN 0066-4812, 09/2014, Volume 46, Issue 4, pp. 992 - 1013
How can we act to contest urban injustice? This article grapples with this question through an analysis of the green ban movement that emerged in Sydney in the...
green bans | urban social movements | the people | urban social justice | Sydney | the right to the city | Green bans | The people | The right to the city | Urban social movements | Urban social justice
green bans | urban social movements | the people | urban social justice | Sydney | the right to the city | Green bans | The people | The right to the city | Urban social movements | Urban social justice
Journal Article
ANTIPODE, ISSN 0066-4812, 09/2014, Volume 46, Issue 4, pp. 992 - 1013
a How can we act to contest urban injustice? This article grapples with this question through an analysis of the green ban movement that emerged in Sydney in...
urban social movements | POPULISM | DEMOCRACY | green bans | the people | urban social justice | Sydney | JUSTICE | GEOGRAPHY | the right to the city | Political aspects | Analysis | Green design | Radicalism | Politicians | Activism | Alliances | Archival research
urban social movements | POPULISM | DEMOCRACY | green bans | the people | urban social justice | Sydney | JUSTICE | GEOGRAPHY | the right to the city | Political aspects | Analysis | Green design | Radicalism | Politicians | Activism | Alliances | Archival research
Journal Article
PROGRESS IN HUMAN GEOGRAPHY, ISSN 0309-1325, 10/2015, Volume 39, Issue 5, pp. 543 - 559
This paper uses Jacque Ranciere's understanding of politics to ask what makes cities political entities. We review existing urban geography debates to identify...
GOVERNANCE | Ranciere | critical theory | CITIES | Urban politics | urban geography | democracy | GEOGRAPHY
GOVERNANCE | Ranciere | critical theory | CITIES | Urban politics | urban geography | democracy | GEOGRAPHY
Journal Article
2008, PLANNING, ENVIRONMENT, CITIES., ISBN 9781403938107
Book
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 481 - 489
Summary Background EGFR overexpression occurs in 27–55% of oesophagogastric adenocarcinomas, and correlates with poor prognosis. We aimed to assess addition of...
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | CETUXIMAB | PROSPECTIVE MULTICENTER | ONCOLOGY | GASTRIC-CANCER | PROGNOSTIC-SIGNIFICANCE | CELL-LINES | METASTATIC COLORECTAL-CANCER | ESOPHAGEAL ADENOCARCINOMA | III TRIAL | Multivariate Analysis | Adenocarcinoma - pathology | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Epirubicin - administration & dosage | Molecular Targeted Therapy | Esophageal Neoplasms - pathology | Early Termination of Clinical Trials | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Female | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Stomach Neoplasms - enzymology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | United Kingdom | Stomach Neoplasms - drug therapy | Chi-Square Distribution | Adenocarcinoma - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Esophageal Neoplasms - enzymology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Care and treatment | Anthracyclines | Product development | Cancer
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | CETUXIMAB | PROSPECTIVE MULTICENTER | ONCOLOGY | GASTRIC-CANCER | PROGNOSTIC-SIGNIFICANCE | CELL-LINES | METASTATIC COLORECTAL-CANCER | ESOPHAGEAL ADENOCARCINOMA | III TRIAL | Multivariate Analysis | Adenocarcinoma - pathology | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Epirubicin - administration & dosage | Molecular Targeted Therapy | Esophageal Neoplasms - pathology | Early Termination of Clinical Trials | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Female | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Stomach Neoplasms - enzymology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | United Kingdom | Stomach Neoplasms - drug therapy | Chi-Square Distribution | Adenocarcinoma - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Esophageal Neoplasms - enzymology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Care and treatment | Anthracyclines | Product development | Cancer
Journal Article
11.
Full Text
Branded cities: outdoor advertising, urban governance, and the outdoor media landscape
Antipode, ISSN 0066-4812, 01/2012, Volume 44, Issue 1, pp. 151 - 174
: In many cities both rich and poor, new forms of outdoor advertising are emerging with potentially significant implications for the nature of the urban...
democratization | outdoor advertising | neoliberalism | urban governance | public space | outdoor media landscape | Democratization | Urban governance | Outdoor media landscape | Public space | Neoliberalism | Outdoor advertising | SPACE | GEOGRAPHY | Public-private sector cooperation
democratization | outdoor advertising | neoliberalism | urban governance | public space | outdoor media landscape | Democratization | Urban governance | Outdoor media landscape | Public space | Neoliberalism | Outdoor advertising | SPACE | GEOGRAPHY | Public-private sector cooperation
Journal Article
2012, 100 key points, ISBN 0415606128, xi, 254
"Solution Focused Brief Therapy: 100 Key Points and Techniques provides a concise and jargon-free guide to the thinking and practice of this exciting approach,...
Professional-Patient Relations | Mental Health Services | methods | Psychotherapy, Brief | Solution-focused brief therapy | Medicine: General Issues | Psychotherapy | Counseling | Brief Therapy | PSYCHOLOGY / Psychotherapy / General
Professional-Patient Relations | Mental Health Services | methods | Psychotherapy, Brief | Solution-focused brief therapy | Medicine: General Issues | Psychotherapy | Counseling | Brief Therapy | PSYCHOLOGY / Psychotherapy / General
Book
2012, Essential coaching skills and knowledge, ISBN 0203144414, ix, 204
"Brief Coaching offers a new approach to coaching by considering how the client will know when they have reached their goal, and what they are already doing to...
Counseling psychology | methods | Psychotherapy, Brief | Counseling | Problem Solving | Personal coaching | Counseling psychologist and client | Goals | Brief psychotherapy | Coaching | Human Resource Development | Executive Coaching | Brief Therapy
Counseling psychology | methods | Psychotherapy, Brief | Counseling | Problem Solving | Personal coaching | Counseling psychologist and client | Goals | Brief psychotherapy | Coaching | Human Resource Development | Executive Coaching | Brief Therapy
Book
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 601 - 611
Summary Background Surgery for colorectal liver metastases results in an overall survival of about 40% at 5 years. Progression-free survival is increased with...
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | COLON-CANCER | 1ST-LINE TREATMENT | WILD-TYPE | PLUS IRINOTECAN | ONCOLOGY | RAS MUTATIONS | OXALIPLATIN | FLUOROURACIL | GEFITINIB RESISTANCE | MRC COIN TRIAL | Capecitabine | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Cetuximab | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Antimitotic agents | Liver cancer | Care and treatment | Chemotherapy | Nuclear radiation | Clinical trials | Metastasis | Antineoplastic agents | Cancer | Analysis
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | COLON-CANCER | 1ST-LINE TREATMENT | WILD-TYPE | PLUS IRINOTECAN | ONCOLOGY | RAS MUTATIONS | OXALIPLATIN | FLUOROURACIL | GEFITINIB RESISTANCE | MRC COIN TRIAL | Capecitabine | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Cetuximab | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Antimitotic agents | Liver cancer | Care and treatment | Chemotherapy | Nuclear radiation | Clinical trials | Metastasis | Antineoplastic agents | Cancer | Analysis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1007 - 1018
Summary Background Dysregulation of the hepatocyte growth factor (HGF)/MET pathway promotes tumour growth and metastasis. Rilotumumab is a fully human,...
Hematology, Oncology and Palliative Medicine | AMPLIFICATION | PHARMACOKINETICS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | C-MET | MONOCLONAL-ANTIBODY | CIRCULATING LEVEL | AMG 102 | CANCER | EXPRESSION | CARCINOMA | Confidence Intervals | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Prognosis | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Stomach Neoplasms - pathology | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Proportional Hazards Models | Esophagogastric Junction - pathology | Survival Rate | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Epirubicin - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Epirubicin - adverse effects | Monoclonal antibodies | Anthracyclines | Index Medicus
Hematology, Oncology and Palliative Medicine | AMPLIFICATION | PHARMACOKINETICS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | C-MET | MONOCLONAL-ANTIBODY | CIRCULATING LEVEL | AMG 102 | CANCER | EXPRESSION | CARCINOMA | Confidence Intervals | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Prognosis | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Stomach Neoplasms - pathology | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Proportional Hazards Models | Esophagogastric Junction - pathology | Survival Rate | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Epirubicin - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Epirubicin - adverse effects | Monoclonal antibodies | Anthracyclines | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 14, pp. 1273 - 1281
In this randomized trial comparing cisplatin plus gemcitabine with gemcitabine alone for the treatment of biliary tract cancer, overall survival and...
TRIAL | SURVIVAL | CHOLANGIOCARCINOMA | MEDICINE, GENERAL & INTERNAL | ACID | GENE | RANDOMIZED PHASE-II | COMBINATION | CARCINOMA | TUMORS | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Biliary Tract Neoplasms - mortality | Patient Compliance - statistics & numerical data | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Deoxycytidine - therapeutic use | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged, 80 and over | Cisplatin - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Aged | Biliary Tract Neoplasms - drug therapy | Neutropenia - chemically induced | Deoxycytidine - analogs & derivatives | Evaluation | Dosage and administration | Drug therapy, Combination | Gemcitabine | Comparative analysis | Cisplatin | Clinical trials | Medical research | Survival analysis | Medical treatment | Index Medicus | Abridged Index Medicus
TRIAL | SURVIVAL | CHOLANGIOCARCINOMA | MEDICINE, GENERAL & INTERNAL | ACID | GENE | RANDOMIZED PHASE-II | COMBINATION | CARCINOMA | TUMORS | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Biliary Tract Neoplasms - mortality | Patient Compliance - statistics & numerical data | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Deoxycytidine - therapeutic use | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged, 80 and over | Cisplatin - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Aged | Biliary Tract Neoplasms - drug therapy | Neutropenia - chemically induced | Deoxycytidine - analogs & derivatives | Evaluation | Dosage and administration | Drug therapy, Combination | Gemcitabine | Comparative analysis | Cisplatin | Clinical trials | Medical research | Survival analysis | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article